• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的行为障碍:多巴胺的作用。

Behavioral disorders in Parkinson's disease: the role of dopamine.

机构信息

Morton and Gloria Shulman Movement Disorder Unit, E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, University of Toronto, Ontario, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada; Parkinson's Disease and Movement Disorders Unit, Neurology Clinic, Hospital Clinic Universitari, University of Barcelona, Barcelona, Spain.

出版信息

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S10-2. doi: 10.1016/S1353-8020(13)70005-1.

DOI:10.1016/S1353-8020(13)70005-1
PMID:24262157
Abstract

Dopaminergic neurons play a major role in controlling movement and behavior. In Parkinson's disease (PD), dopaminergic denervation is responsible for a number of motor and non-motor symptoms including tremor, rigidity and akinesia and as well apathy, impulsivity and other behavioral complications frequently reported in these patients. In this review, we will summarize the possible proposed dopaminergic mechanisms responsible for these complications in PD, focusing mainly on the role of this neurotransmitter in behavioral symptoms.

摘要

多巴胺能神经元在控制运动和行为方面起着重要作用。在帕金森病(PD)中,多巴胺能神经元丧失负责许多运动和非运动症状,包括震颤、僵硬和运动不能,以及这些患者经常报告的冷漠、冲动和其他行为并发症。在这篇综述中,我们将总结可能导致 PD 中这些并发症的多巴胺能机制,主要关注这种神经递质在行为症状中的作用。

相似文献

1
Behavioral disorders in Parkinson's disease: the role of dopamine.帕金森病中的行为障碍:多巴胺的作用。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S10-2. doi: 10.1016/S1353-8020(13)70005-1.
2
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.帕金森病的非运动症状:多巴胺能病理生理学与治疗
Lancet Neurol. 2009 May;8(5):464-74. doi: 10.1016/S1474-4422(09)70068-7.
3
Non-motor extranigral signs and symptoms in Parkinson's disease.帕金森病的非运动性外显体征和症状。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9.
4
[Non-motor disorders in Parkinson's disease].[帕金森病中的非运动障碍]
Rev Neurol. 2008;47(5):261-70.
5
Dopaminergic dysregulation syndrome in Parkinson's disease.帕金森病多巴胺能调节障碍综合征。
J Neurol Sci. 2011 Nov 15;310(1-2):271-5. doi: 10.1016/j.jns.2011.07.012. Epub 2011 Aug 25.
6
New pharmacological options for treating advanced Parkinson's disease.治疗晚期帕金森病的新药理学选择。
Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5.
7
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.帕金森病中的多巴胺调节障碍综合征、成瘾及行为改变
Parkinsonism Relat Disord. 2008;14(4):273-80. doi: 10.1016/j.parkreldis.2007.09.007. Epub 2007 Nov 7.
8
The nonmotor symptoms of Parkinson's disease--an overview.帕金森病的非运动症状——概述。
Mov Disord. 2010;25 Suppl 1:S123-30. doi: 10.1002/mds.22786.
9
Nonmotor symptom complex of Parkinson's disease--an under-recognized entity.帕金森病的非运动症状复合体——一个未被充分认识的实体。
J Assoc Physicians India. 2011 May;59:302-8, 313.
10
Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.帕金森病手术后非运动性多巴胺戒断综合征:预测因素和潜在的中脑边缘去神经支配。
Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17.

引用本文的文献

1
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment.针灸调节微生物群-肠-脑轴:一种治疗帕金森病的新策略。
Front Aging Neurosci. 2025 Aug 7;17:1640389. doi: 10.3389/fnagi.2025.1640389. eCollection 2025.
2
Deep brain stimulation-induced two manners to eliminate bursting for Parkinson's diseases: synaptic current and bifurcation mechanisms.深部脑刺激诱导的消除帕金森病爆发的两种方式:突触电流和分岔机制。
Cogn Neurodyn. 2025 Dec;19(1):78. doi: 10.1007/s11571-025-10267-5. Epub 2025 May 19.
3
Unraveling the Bone-Brain Axis: A New Frontier in Parkinson's Disease Research.
解析骨-脑轴:帕金森病研究的新前沿
Int J Mol Sci. 2024 Nov 29;25(23):12842. doi: 10.3390/ijms252312842.
4
Biomarkers of Parkinson's Disease: From Basic Research to Clinical Practice.帕金森病的生物标志物:从基础研究到临床实践。
Aging Dis. 2024 Aug 1;15(4):1813-1830. doi: 10.14336/AD.2023.1005.
5
Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action.单胺氧化酶 B 抑制剂与帕金森病的认知功能:超越主要作用机制。
Curr Neuropharmacol. 2023;21(5):1214-1223. doi: 10.2174/1570159X20666220905102144.
6
Neural correlates of working memory and compensation at different stages of cognitive impairment in Parkinson's disease.帕金森病认知障碍不同阶段工作记忆和补偿的神经相关性。
Neuroimage Clin. 2022;35:103100. doi: 10.1016/j.nicl.2022.103100. Epub 2022 Jun 27.
7
Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.额颞叶痴呆和皮质下(共)病变负担的精神症状:新的认识。
Brain. 2023 Jan 5;146(1):307-320. doi: 10.1093/brain/awac043.
8
Association Between Pathophysiological Mechanisms of Diabetic Retinopathy and Parkinson's Disease.糖尿病视网膜病变的病理生理机制与帕金森病的关系。
Cell Mol Neurobiol. 2022 Apr;42(3):665-675. doi: 10.1007/s10571-020-00953-9. Epub 2020 Sep 3.
9
Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.丁酸钠通过加重 MPTP 诱导的小鼠模型中的神经炎症和结肠炎症加剧帕金森病。
Neurochem Res. 2020 Sep;45(9):2128-2142. doi: 10.1007/s11064-020-03074-3. Epub 2020 Jun 16.
10
Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.帕金森病患者在多巴胺药物治疗下反应性、前瞻性和认知领域的冲动性:多领域损伤的证据。
PLoS One. 2019 Feb 13;14(2):e0210880. doi: 10.1371/journal.pone.0210880. eCollection 2019.